MPR weekly dose #63 - COVID-19 vaccine admin scheduling and production updates; A diagnostic test that is giving false negative results; Bristol Myers Squibb withdraws an indication for Opdivo; And experts vote on the best diets for 2021.
On the first MPR pod of 2021 we cover the latest COVID-19 news including admin. scheduling and production news; A diagnostics test that is giving false negative results; Bristol Myers Squibb withdraw ...
8 Jan 20218min
MPR Weekly Dose #62 - Major vaccine developments; FDA authorizes rapid at-home COVID test; New findings for glucosamine supplementation; And a novel budesonide oral suspension gets Priority Review
Its been a long year, but the monumental efforts to achieve a COVID-19 vaccine are bearing some fruits, we about that, and also a fully at home diagnostic COVID test, as well as new findings related t...
18 Des 20209min
MPR Weekly Dose #61 - Sitagliptin findings in pediatrics; Obesity treatment gains expanded approval; The FDA issue a CRL; And a new transdermal contraceptive
This week we cover new findings for the diabetes drug sitagliptin in pediatrics; An obesity treatment has approval expanded; The FDA issue a Complete Response Letter for an outpatient alternative trea...
11 Des 20209min
MPR Weekly Dose #60 - The FDA stand by remdesivir; Who should get the vaccine first? Xolair and Hetlioz gain expanded approvals; And a novel neuroblastoma treatment
This week we cover a back and forth between the FDA and the WHO over remdesivir efficacy; Recommendations for who should get a COVID vaccine first; Xolair and Hetlioz have approval expansions; And a n...
4 Des 20209min
MPR Weekly Dose #59 - The latest on vaccine news from Moderna, and BioNTech and Pfizer as they release more trial data; A at-home diagnostic test; Keytruda gains expanded approval; and more
The latest on vaccine news from Moderna, and BioNTech and Pfizer as they release more trial data; A at-home diagnostic test is approved; Keytruda gains expanded approval; and all the rest of the drug ...
20 Nov 202011min
MPR Weekly Dose #58 - Major developments in COVID vaccine and antibody treatments; Also an FDA Advisory Committee vote on what would be the first Alzheimer drug in decades.
Major developments in COVID-19 vaccine and antibody treatments: Are we close to having a vaccine gain Emergency Use Authorization? The antibody bamlanivimab is given Emergency Use Authorization; An NI...
13 Nov 202012min
MPR Weekly Dose #57 - NDA in diabetes; Post-op implant pain Tx; DEA schedules new opioid; FDA lists 200+ drugs; Rifaximin and other drugs in the pipeline news
This week we cover a new treatment submission to the FDA for the prevention of diabetes; The launch of a bupivacaine implant to treat post op pain; The DEA schedules a newly approved opioid; The FDA c...
6 Nov 20209min
MPR Weekly Dose Episode #56 - Antibody responses; Convalescent plasma; Nasal spray for diabetic gastroparesis; Colorectal cancer screening recommendations; New dry eye treatment; And movie trivia!
This week: The study that identified factors associated with strong antibody responses to COVID; How convalescent plasmas benefits may be limited; A nasal spray to treat diabetic gastroparesis; Recomm...
30 Okt 20206min
